SLC16A1 and cancer: It is likely that additional signals and microenvironmental conditions exert important influence on SLC16A1/MCT-1 expression, influences that are also important to define now that we know MCT-1 is the single most important transporter of the candidate cancer drug 3-bromopyruvate.